Company / Total Assets
Repligen Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$2.9B
FY2025
5-year range
$2.4B / $2.9B
FY2021-FY2025
Trend
+4.2%
vs FY2024
Sector context
#33 of 214
Health Care
What the data says
Repligen's total assets of $2.9B is higher than 85% of companies in the Health Care sector (FY2025). Improved from $2.8B to $2.9B over the past 2 years.
Based on SEC 10-K filings.
$2.9B in FY2025 with a 5-year CAGR of +9.2%. Top quartile in the Health Care sector.
Improved from $2.8B to $2.9B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +5.3%
- 5-Year CAGR
- +9.2%
- 10-Year CAGR
- -
Sector benchmark
Top 15% in Health CareTop 15% of 214This company $2.9B Sector average $7.5B
▼
-60.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.2%, indicating consistent growth.
- In FY2025, total assets increased 4.2% year-over-year.
- Ranks #33 out of 214 companies in the Health Care sector.
- Lowest total assets in the period was in FY2016.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.9B | +4.2% |
| FY2024 | $2.8B | -0.1% |
| FY2023 | $2.8B | +12.1% |
| FY2022 | $2.5B | +7.1% |
| FY2021 | $2.4B | +23.9% |
| FY2020 | $1.9B | +35.9% |
| FY2019 | $1.4B | +80.7% |
| FY2018 | $774.6M | +4.2% |
| FY2017 | $743.5M | +157.4% |
| FY2016 | $288.9M | +97.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026